InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.31
(
1.19%
)
US TECH 100
17,006.36
(
1.51%
)
Dow Jones
38,496.15
(
0.67%
)
Brent Oil
87.21
(
0.93%
)
Bitcoin
66,762.70
(
-0.14%
)
Post# of 19856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ombowstring

Send PM Follow Ignore
Followers 24
Posts 5031
Boards Moderated 0
Alias Born 09/27/2005

ombowstring

Re: gfp927z post# 15047

Monday, 10/21/2019 10:19:25 PM

Monday, October 21, 2019 10:19:25 PM

Post# of 19856
The articles that you copied and pasted re FOMX are a bit outdated. They just received FDA approval for AMZEEQ, formerly known as FMX101, according to the PR released on Oct. 18.

And, >>>Foamix is seeking approval of FMX103 for the treatment of moderate-to-severe papulopustular rosacea in adults. The FDA has set June 2nd, 2020 as the Prescription Drug User Fee Act (PDUFA) action date.<<<

http://www.foamix.com/news-releases/news-release-details/foamix-announces-fda-acceptance-its-new-drug-application-fmx103

And they just entered into a settlement and licensing deal with Teva -

http://www.foamix.com/news-releases/news-release-details/foamix-announces-settlement-litigation-teva-relating-finacea

Looking real good, I think.

http://www.foamix.com/

http://www.foamix.com/press-releases
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up